Evidence map›Paper›PMID 34305912›Full record

ArticleFrontiers in immunology2021

Comparative Analysis of the Measles Antibody Levels in Healthy Medical Personnel of Maternity Ward and Women in Labor.

Mikhail Petrovich Kostinov, Pavel Ivanovich Zhuravlev, Lylia Solomonovna Gladkova, Kirill Vadimovich Mashilov, Valentina Borisovna Polishchuk, Anna Dmitrievna Shmitko, Veronika Nikolaevna Zorina, Dmitriy Alexeyevich Blagovidov, Dmitriy Vladimirovich Pahomov, Anna Egorovna Vlasenko and 2 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Mikhail Petrovich KostinovDepartment of Epidemiology and Modern Vaccination Technologies of I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Pavel Ivanovich ZhuravlevLaboratory of Vaccine Prophylaxis and Immunotherapy of Allergic Diseases of I.I.Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia.
Lylia Solomonovna GladkovaCity D.D. Pletnev Clinical Hospital of the Moscow City Health Department, Moscow, Russia.
Kirill Vadimovich MashilovLaboratory of Vaccine Prophylaxis and Immunotherapy of Allergic Diseases of I.I.Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia.
Valentina Borisovna PolishchukLaboratory of Vaccine Prophylaxis and Immunotherapy of Allergic Diseases of I.I.Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia.
Anna Dmitrievna ShmitkoLaboratory of Vaccine Prophylaxis and Immunotherapy of Allergic Diseases of I.I.Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia.
Veronika Nikolaevna ZorinaDeputy Director for Science of Institute of Highly Pure Biopreparations, Saint Petersburg, Russia.
Dmitriy Alexeyevich BlagovidovLaboratory of Vaccine Prophylaxis and Immunotherapy of Allergic Diseases of I.I.Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia.
Dmitriy Vladimirovich PahomovLaboratory of Vaccine Prophylaxis and Immunotherapy of Allergic Diseases of I.I.Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia.
Anna Egorovna VlasenkoMedical Cybernetics and Informatics Department of Novokuznetsk State Institute of Advanced Training of Physicians-Branch of the "Russian Medical Academy of Continuous Professional Education" of the Ministry of Healthcare of the Russian Federation, Novokuznetsk, Russia.
Alexey Anatolevich RyzhovLaboratory of Vaccine Prophylaxis and Immunotherapy of Allergic Diseases of I.I.Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia.
Ekaterina Alexandrovna KhromovaLaboratory of Vaccine Prophylaxis and Immunotherapy of Allergic Diseases of I.I.Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia.
Research Institute of Vaccines and Sera. Mechnikov of the Russian Academy of Medical Sciences · RUCity Clinical Hospital · RURussian Medical Academy of Continuous Professional Education · RUState Research Institute of Highly Pure Biopreparations · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been proven that post-vaccination immunity to measles virus after two doses of vaccine is not able to persistently protect against infection throughout life. The goal of this research was to determine the immune layer to the measles virus among women in labor and maternity ward personnel in the same medical institution. The levels of IgG antibodies to measles virus in the umbilical cord blood of 594 women in labor and 88 workers of the maternity ward were studied by ELISA. It was revealed that 22.7% of umbilical cord blood serum samples from parturient women and 21.4% of blood serum samples from maternity ward personnel were seronegative (<0.18 IU/ml). Levels of IgG antibodies to measles virus in low values (<1.0 IU/ml) were detected in 67% of blood serum samples among women in labor and 68.9% among employees of the maternity ward. Among women in labor, women under 35 years of age are at the highest risk of contracting measles; the proportion of women with low levels of protective antibodies in this age group was almost 70%, and the proportion of women without protective levels of antibodies was 23%. Compared with the age group 36-43, the age of women in labor under 35 was associated with a higher chance of not having immune protection against infection with measles virus OR [95% CI] = 2.2 [1.1-4.5] (p = 0.02) or had a low level of protection OR [95% CI] = 1.9 [1.2-3.0] (p = 0.001). It was also found that among women over 35 years of age, the proportion of persons with a high level of antibodies in women in labor was statistically significantly higher than among members of the maternity ward staff (13 and 0%, respectively, p = 0.007). Thus, maternity ward employees and women in labor constitute a risk group for measles due to the presence of a high proportion of seronegative persons among women of childbearing age (both maternity ward employees and women in labor). These conditions create the need to revise current approaches to present vaccination procedures, especially in the current epidemiological situation with COVID-19.

Indexed as

AdultAge DistributionAntibodies, ViralFemaleHealth PersonnelHumansImmunoglobulin GMeaslesMeasles VaccineMeasles virusMiddle AgedObstetrics and Gynecology Department, HospitalPregnancyYoung AdultAntibodies, ViralImmunoglobulin GMeasles Vaccinematernity wardmeasles IgG antibodiesmeasles preventionseropositivitywomen in labor

Identifiers

PMID34305912
PMCPMC8298000
OpenAlexW3182420816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.